These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30420229)

  • 21. GAIN Act legislation: is it enough?
    Tillotson GS
    Lancet Infect Dis; 2012 Nov; 12(11):823-4. PubMed ID: 23099071
    [No Abstract]   [Full Text] [Related]  

  • 22. Scientists seek antibiotic adjuvants.
    Kuehn BM
    JAMA; 2011 Nov; 306(20):2203-4. PubMed ID: 22110097
    [No Abstract]   [Full Text] [Related]  

  • 23. Overview: Global and Local Impact of Antibiotic Resistance.
    Watkins RR; Bonomo RA
    Infect Dis Clin North Am; 2016 Jun; 30(2):313-322. PubMed ID: 27208761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibiotic Resistance: The Need For a Global Strategy.
    Elder DP; Kuentz M; Holm R
    J Pharm Sci; 2016 Aug; 105(8):2278-87. PubMed ID: 27397433
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antimicrobial resistance: the Hydra among us.
    Lancet Infectious Diseases
    Lancet Infect Dis; 2015 Nov; 15(11):1243. PubMed ID: 26531028
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of new antibacterials: a laudable aim, but what is the value?
    Tillotson GS
    Clin Infect Dis; 2010 Sep; 51(6):752-3; author reply 754-5. PubMed ID: 20731567
    [No Abstract]   [Full Text] [Related]  

  • 27. Tackling antibiotic resistance.
    Bush K; Courvalin P; Dantas G; Davies J; Eisenstein B; Huovinen P; Jacoby GA; Kishony R; Kreiswirth BN; Kutter E; Lerner SA; Levy S; Lewis K; Lomovskaya O; Miller JH; Mobashery S; Piddock LJ; Projan S; Thomas CM; Tomasz A; Tulkens PM; Walsh TR; Watson JD; Witkowski J; Witte W; Wright G; Yeh P; Zgurskaya HI
    Nat Rev Microbiol; 2011 Nov; 9(12):894-6. PubMed ID: 22048738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerating global innovation to address antibacterial resistance: introducing CARB-X.
    Outterson K; Rex JH; Jinks T; Jackson P; Hallinan J; Karp S; Hung DT; Franceschi F; Merkeley T; Houchens C; Dixon DM; Kurilla MG; Aurigemma R; Larsen J
    Nat Rev Drug Discov; 2016 Sep; 15(9):589-590. PubMed ID: 27469032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [How to explain antibiotic resistance?].
    Woerther PL; Andremont A
    Rev Prat; 2012 Sep; 62(7):967-71. PubMed ID: 23236870
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Report reveals scope of US antibiotic resistance threat.
    Hampton T
    JAMA; 2013 Oct; 310(16):1661-3. PubMed ID: 24150445
    [No Abstract]   [Full Text] [Related]  

  • 31. Emerging antimicrobial resistance and newer tools to address the resistance.
    Goyal PK; Semwal A; Prakash A; Medhi B
    Indian J Pharmacol; 2019; 51(5):291-295. PubMed ID: 31831917
    [No Abstract]   [Full Text] [Related]  

  • 32. Management of Neonates Born at ≥35 0/7 Weeks' Gestation With Suspected or Proven Early-Onset Bacterial Sepsis.
    Puopolo KM; Benitz WE; Zaoutis TE; ;
    Pediatrics; 2018 Dec; 142(6):. PubMed ID: 30455342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neonatal bloodstream infections in a Ghanaian Tertiary Hospital: Are the current antibiotic recommendations adequate?
    Labi AK; Obeng-Nkrumah N; Bjerrum S; Enweronu-Laryea C; Newman MJ
    BMC Infect Dis; 2016 Oct; 16(1):598. PubMed ID: 27776490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Ethics of Antibiotic Resistance: Towards an Agenda for Feasible and Justified Global Health Policy.
    Munthe C; Nijsingh N; de Fine Licht K; Larsson DGJ
    Bioethics; 2019 Sep; 33(7):731-733. PubMed ID: 31423606
    [No Abstract]   [Full Text] [Related]  

  • 35. Questions about the 10 x '20 Initiative.
    Outterson K; Powers JH; Gould IM; Kesselheim AS
    Clin Infect Dis; 2010 Sep; 51(6):751-2; author reply 754-5. PubMed ID: 20731566
    [No Abstract]   [Full Text] [Related]  

  • 36. The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.
    Kostyanev T; Bonten MJ; O'Brien S; Steel H; Ross S; François B; Tacconelli E; Winterhalter M; Stavenger RA; Karlén A; Harbarth S; Hackett J; Jafri HS; Vuong C; MacGowan A; Witschi A; Angyalosi G; Elborn JS; deWinter R; Goossens H
    J Antimicrob Chemother; 2016 Feb; 71(2):290-5. PubMed ID: 26568581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Letter in response to the Infectious Diseases Society of America's 10 x '20 Initiative.
    Burgess DS; Slain D; Mohr J; Wong-Beringer A; Destache C; Suda K
    Clin Infect Dis; 2010 Sep; 51(6):753; author reply 754-5. PubMed ID: 20731568
    [No Abstract]   [Full Text] [Related]  

  • 38. Short summary of Swedres 2005, a report on Swedish antibiotic utilisation and resistance.
    Cars O; Olsson-Liljequist B; Lundh K
    Euro Surveill; 2007 Mar; 12(3):225. PubMed ID: 17439810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combating antibiotic resistance, mitigating future threats and ongoing initiatives.
    Velez R; Sloand E
    J Clin Nurs; 2016 Jul; 25(13-14):1886-9. PubMed ID: 26991135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Worldwide Endemicity of a Multidrug-Resistant Staphylococcus capitis Clone Involved in Neonatal Sepsis.
    Butin M; Martins-Simões P; Rasigade JP; Picaud JC; Laurent F
    Emerg Infect Dis; 2017 Mar; 23(3):538-539. PubMed ID: 28221122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.